MIF and breast cancer: Therefore, combination therapy utilising AEP‐targeted inhibitors and CD74/MIF pathway inhibitors may provide comprehensive inhibition of distant organ metastasis in breast cancer, potentially emerging as a promising clinical strategy for future therapeutic development.